Clinical Trial Update: NW-301 TCR-T in Patients With Advanced Solid Tumor [Phase 1]

View source ↗

Summary

This document describes a Phase 1 clinical trial of NW-301 TCR-T therapy in patients with advanced solid tumors; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• NW-301 TCR-T

Snippet

Sponsor: Peking University | Conditions: Tumor, Solid | Phase 1 | Status: NOT_YET_RECRUITING